Eli Lilly (LLY)
(Delayed Data from NYSE)
$865.82 USD
+0.82 (0.09%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $865.05 -0.77 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LLY 865.82 +0.82(0.09%)
Will LLY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LLY
Best ETF Areas of Last Week
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Apple Joins A.I. Race; Lilly Thumbs-Up on Alzheimer's Drug
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Other News for LLY
10 Health Care Stocks With Whale Alerts In Today's Session
Wall Street’s most overbought stocks include NVDA, COST, LLY, and others
Why Are Stocks Down Today?
Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug
Top 4 Health Care Stocks That May Keep You Up At Night This Month